Introducing
Regenerate. Restore. Relieve.
India's first autologous exosome kitIndia's first autologous exosome kit enriched with growth factor concentrate represents a breakthrough in regenerative medicine — combining autologous exosomes with platelet-derived growth factors (GFs) to accelerate healing, reduce inflammation, and restore mobility naturally.
Exosomes — nature's nanocarriers
Exosomes are nanosized "biological messengers" released by cells. Rich in proteins, lipids, and genetic material, they deliver vital healing signals that promote repair and regeneration at the cellular level.
ELISA analysis verifies OrthoGain's elevated levels of PDGF, VEGF, EGF, and TGF-β, ensuring strong therapeutic activity. Consistent biomarker enrichment supports faster healing, improved outcomes, and better patient satisfaction.
The synergy of OrthoGain™. By combining autologous exosomes (loaded with mRNA & proteins) and concentrated growth factors, OrthoGain™ delivers a pioneering regenerative solution for orthopaedics and sports medicine.
Mechanism
OrthoGain works faster due to direct exosome-mediated cellular communication — lower inflammation, better patient comfort and quicker visible results.
From ligament tears, tendon injuries, and fractures.
Without steroid side effects.
Of muscles, cartilage, and bone.
And performance, for athletes and active patients.
No rejection or allergy risk.
Clinical applications
Chairside preparation
Six steps, from venous draw to filtered autologous product.
Head to head
| Parameters | PRP | GFC | EXOS-GFC |
|---|---|---|---|
| Composition | Platelets with plasma | Platelet-derived growth factors | Autologous exosomes + growth factors |
| Mechanism | Indirect GF release | Direct GF delivery | Direct cellular communication + potent regenerative signaling |
| Regenerative capacity | Moderate | Improved | Superior — targets inflammation and stimulates true regeneration |
| Purity | Contains RBCs/WBCs | Contains cell debris | RBC-free, cell-free, highly purified exosomes |
| Onset of results | 4–6 weeks | 2–3 weeks | 1–2 weeks |
Nanoparticle Tracking Analysis (NTA)
Nanoparticle Tracking Analysis is a technique used to measure the size distribution and concentration of nanoparticles, including exosomes. NTA combines the principles of laser light scattering and Brownian motion to provide detailed insight into exosome populations.
2.05e+13 particles/ml
Original exosome concentration.
85.7% of particles between 30–150 nm, with a therapeutic peak at 100 nm.
>98% exosome and growth factor content with negligible impurities. NTA demonstrates excellent batch consistency, ensuring predictable regenerative outcomes.
What ships
Approved by the Central
Drugs Standard Control Organisation, India.
Get in touch
For orthopaedic surgeons, sports medicine physicians, hospitals and distribution partners. Tell us about your practice and we will send pricing, the full protocol and training details.
Kamal Encon Industries Limited
Plot No. 917, Sector-68, IMT Faridabad – 121001
Haryana, India
+91 99711 66553 ·
+91 80762 87050
info@kamalmedtech.com
Sweden office
Kamal Encon Psilox AB, Vallvägen 4A, S75651, Uppsala, Sweden
Ortho